Profile | GDS4284 / 228745_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 6017.26 | 94 |
GSM687648 | Patient 402 control | 5510.22 | 94 |
GSM687653 | Patient 403 control | 4564.47 | 92 |
GSM687658 | Patient 404 control | 3902.14 | 91 |
GSM687663 | Patient 411 control | 4482.07 | 93 |
GSM687668 | Patient 422 control | 3121.08 | 89 |
GSM687673 | Patient 424 control | 2747.57 | 88 |
GSM687678 | Patient 425 control | 4117.66 | 92 |
GSM687683 | Patient 427 control | 3899.85 | 91 |
GSM687688 | Patient 428 control | 3608.76 | 91 |
GSM687695 | Patient 441 control | 3870.38 | 92 |
GSM687699 | Patient 443 control | 4105.43 | 92 |
GSM687704 | Patient 444 control | 3396.37 | 90 |
GSM687707 | Patient 448 control | 3830.45 | 91 |
GSM687712 | Patient 449 control | 6200.32 | 95 |
GSM687719 | Patient 450 control | 3443.36 | 90 |
GSM687724 | Patient 451 control | 6017.62 | 95 |
GSM687728 | Patient 452 control | 7316.85 | 96 |
GSM687646 | Patient 401 treated 24h | 6189.19 | 95 |
GSM687649 | Patient 402 treated 24h | 5341.18 | 94 |
GSM687665 | Patient 411 treated 24h | 4850.29 | 93 |
GSM687651 | Patient 402 treated 4 weeks | 4604.83 | 93 |
GSM687667 | Patient 411 treated 4 weeks | 4351.23 | 92 |
GSM687670 | Patient 422 treated 24h | 3213.22 | 89 |
GSM687671 | Patient 422 treated 4 weeks | 3162.27 | 89 |
GSM687654 | Patient 403 treated 24h | 3925.34 | 91 |
GSM687675 | Patient 424 treated 24h | 3070.69 | 89 |
GSM687685 | Patient 427 treated 24h | 3933.88 | 91 |
GSM687656 | Patient 403 treated 4 weeks | 3807.4 | 91 |
GSM687677 | Patient 424 treated 4 weeks | 2584.64 | 87 |
GSM687687 | Patient 427 treated 4 weeks | 3452.31 | 90 |
GSM687692 | Patient 428 treated 4h | 4291.36 | 92 |
GSM687716 | Patient 449 treated 4h | 4558.59 | 92 |
GSM687722 | Patient 450 treated 4h | 3812.67 | 91 |
GSM687680 | Patient 425 treated 24h | 4604.56 | 93 |
GSM687690 | Patient 428 treated 24h | 5016.37 | 93 |
GSM687700 | Patient 443 treated 24h | 4486.19 | 93 |
GSM687705 | Patient 444 treated 24h | 4419.71 | 92 |
GSM687714 | Patient 449 treated 24h | 5460.88 | 94 |
GSM687721 | Patient 450 treated 24h | 3817.89 | 91 |
GSM687682 | Patient 425 treated 4 weeks | 5021.16 | 93 |
GSM687694 | Patient 428 treated 4 weeks | 3678.24 | 91 |
GSM687702 | Patient 443 treated 4 weeks | 4466.9 | 93 |
GSM687718 | Patient 449 treated 4 weeks | 4847.51 | 93 |
GSM687723 | Patient 450 treated 4 weeks | 3216.26 | 89 |
GSM687661 | Patient 404 treated 4h | 3861.77 | 91 |
GSM687710 | Patient 448 treated 4h | 3171.33 | 89 |
GSM687726 | Patient 451 treated 4h | 5162.97 | 94 |
GSM687730 | Patient 452 treated 4h | 2877.05 | 90 |
GSM687660 | Patient 404 treated 24h | 7677.09 | 96 |
GSM687697 | Patient 441 treated 24h | 3726.44 | 91 |
GSM687709 | Patient 448 treated 24h | 3506.28 | 90 |
GSM687725 | Patient 451 treated 24h | 5999.51 | 95 |
GSM687729 | Patient 452 treated 24h | 9474.69 | 97 |
GSM687727 | Patient 451 treated 4 weeks | 4744.21 | 93 |
GSM687731 | Patient 452 treated 4 weeks | 5482.7 | 94 |